Brian T. David, Ph.D. - Publications
Affiliations: | 2009 | University of California, Irvine, Irvine, CA |
Year | Citation | Score | |||
---|---|---|---|---|---|
2023 | Metcalfe M, David BT, Langley BC, Hill CE. Elevation of NAD by nicotinamide riboside spares spinal cord tissue from injury and promotes locomotor recovery. Experimental Neurology. 114479. PMID 37454712 DOI: 10.1016/j.expneurol.2023.114479 | 0.348 | |||
2022 | Raue KD, David BT, Fessler RG. The spinal cord-gut-immune axis and its implications on therapeutic development for spinal cord injury. Journal of Neurotrauma. PMID 36509451 DOI: 10.1089/neu.2022.0264 | 0.361 | |||
2020 | Platt A, David BT, Fessler ARG. Stem Cell Clinical Trials in Spinal Cord Injury: A Brief Review of Studies in the United States. Medicines (Basel, Switzerland). 7. PMID 32408562 DOI: 10.3390/Medicines7050027 | 0.41 | |||
2019 | Trawczynski M, Liu G, David BT, Fessler RG. Restoring Motor Neurons in Spinal Cord Injury With Induced Pluripotent Stem Cells. Frontiers in Cellular Neuroscience. 13: 369. PMID 31474833 DOI: 10.3389/Fncel.2019.00369 | 0.384 | |||
2014 | David BT, Sampath S, Dong W, Heiman A, Rella CE, Elkabes S, Heary RF. A toll-like receptor 9 antagonist improves bladder function and white matter sparing in spinal cord injury. Journal of Neurotrauma. 31: 1800-6. PMID 24936867 DOI: 10.1089/Neu.2014.3357 | 0.437 | |||
2013 | David BT, Ratnayake A, Amarante MA, Reddy NP, Dong W, Sampath S, Heary RF, Elkabes S. A toll-like receptor 9 antagonist reduces pain hypersensitivity and the inflammatory response in spinal cord injury. Neurobiology of Disease. 54: 194-205. PMID 23313320 DOI: 10.1016/J.Nbd.2012.12.012 | 0.382 | |||
2010 | David BT, Steward O. Deficits in bladder function following spinal cord injury vary depending on the level of the injury. Experimental Neurology. 226: 128-35. PMID 20713043 DOI: 10.1016/J.Expneurol.2010.08.014 | 0.419 | |||
Show low-probability matches. |